文献速递妇科生殖医学

子宫内膜异位症女性健康相关生活质量降低持续至晚育龄:基于人群队列31岁与46岁分析

Women with endometriosis have decreased health-related quality of life until late fertile age: a population-based cohort analysis at ages 31 and 46 years.
PubMed 文献 · Hum Reprod · 2025-01-01

基于芬兰北部1966年出生队列,纳入419例子宫内膜异位症女性和3279例对照,在31岁和46岁用15D量表评估健康相关生活质量(HRQoL)。子宫内膜异位症女性两个年龄点HRQoL总分均较低但未达临床显著性(31岁0.944 vs 0.951,P=0.04;46岁0.916 vs 0.924,P=0.03);抑郁、不孕、疼痛和总体健康差似乎贡献于此。

要点

  • 子宫内膜异位症女性31岁和46岁HRQoL总分低于对照,但未达临床显著性(变化阈值±0.015)。
  • 31岁时睡眠、抑郁、痛苦维度受损,46岁时仅睡眠维度受损。
  • 调整BMI、教育、吸烟后,两个年龄点低HRQoL风险均显著(31岁OR 1.42,46岁OR 1.42)。

核心结论

  • 子宫内膜异位症女性HRQoL降低持续至晚育龄,但较非子宫内膜异位症者仅轻度降低。
  • 抑郁、不孕、疼痛和总体健康差似乎贡献于HRQoL受损。
  • 支持生育、激素治疗和获得三级医疗可能提供改善HRQoL的方案(作者认为)。

研究设计与样本

  • 基于芬兰北部1966年出生队列(NFBC1966)的人群队列分析,纳入31岁和46岁两个数据收集时间点。
  • 子宫内膜异位症诊断来自自报问卷和/或芬兰健康与福利研究所医疗保健登记(CRHC)1972-2020年ICD编码数据链接。
  • 共识别419例子宫内膜异位症女性和3279例无子宫内膜异位症女性;诊断基于CRHC ICD数据(n=298)和/或医生诊断的自报病史(n=283)。
  • 31岁问卷完成:子宫内膜异位症组252例,参照组2057例;46岁问卷完成:子宫内膜异位症组302例,参照组2626例。
  • HRQoL采用15D量表评估,总分和维度水平值范围0到1,1表示完全健康,0表示死亡;考虑多个混杂因素。

主要发现

  • 子宫内膜异位症女性HRQoL总分在31岁(0.944 vs 0.951,P=0.04)和46岁(0.916 vs 0.924,P=0.03)均低于无子宫内膜异位症女性,但未达临床显著性(阈值±0.015)。
  • 31岁时子宫内膜异位症女性15D单指数在「睡眠」「抑郁」「痛苦」维度受损;46岁时「睡眠」维度受损。
  • 31岁至46岁期间,子宫内膜异位症组和参照组HRQoL均随时间下降。
  • 非调整分析中,子宫内膜异位症女性HRQoL评分处于最低四分位的频率与无子宫内膜异位症女性相近:31岁OR 1.33(95%CI 1.00-1.78),46岁OR 1.28(95%CI 0.98-1.66)。
  • 调整BMI、教育和吸烟的风险模型中,子宫内膜异位症病例两个时间点低HRQoL风险均显著:31岁OR 1.42(95%CI 1.06-1.91),46岁OR 1.42(95%CI 1.06-1.89);31岁模型纳入产次和避孕药具使用后OR 1.40(95%CI 1.03-1.91)。

关键数值与推荐

  • HRQoL临床显著性阈值设为15D总分变化±0.015。
  • 15D总分和维度水平值范围0到1,1表示完全健康,0表示死亡。

临床怎么用

  • 作者认为患者照护中应针对「睡眠」「抑郁」「痛苦」等HRQoL条目进行干预。
  • 作者认为支持生育、激素治疗和获得三级医疗可能提供改善子宫内膜异位症女性HRQoL的方案。

局限性

  • 鉴于子宫内膜异位症已知的认知不足和诊断延迟,参照组中可能存在未诊断病例,可能导致研究组间差异被低估。
  • 本研究数据集无法识别住院期间的干预类型。
  • 研究人群种族较为同质,可能无法推广至其他种族。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the health-related quality of life (HRQoL) at fertile and late fertile age in women with history of endometriosis? SUMMARY ANSWER: Women with endometriosis have lower HRQoL until late fertile age and depression, infertility, pain, and poor general health seem to contribute to this impairment, whereas BMI, education, smoking, parity, current use of contraceptives, and contact to tertiary care have positive association with HRQoL in this population. WHAT IS KNOWN ALREADY: Women with endometriosis are known to have decreased HRQoL at fertile age, however, studies concerning late fertile age and beyond are lacking. STUDY DESIGN, SIZE, DURATION: This study utilized Northern Finland Birth Cohort 1966, which is a unique, population-based dataset comprising all expected births in 1966. The present study included data from two collection time points, at ages 31 (fertile age) and 46 years (late fertile age), including both questionnaire and clinical measures. The endometriosis diagnosis was obtained from self-reported questionnaires as well as through a data linkage to the Finnish Institute for Health and Welfare Care Register for Health Care (CRHC) to obtain International Classification of Diseases (ICD) code data from years 1972-2020. PARTICIPANTS/MATERIALS, SETTING, METHODS: Altogether, 419 women with and 3279 women without endometriosis were identified. The diagnosis for endometriosis was based on either CRHC-derived ICD data (n = 298) and/or self-reported history of endometriosis diagnosed by a physician (n = 283). HRQoL was assessed with the 15D instrument, which is a generic, comprehensive, and standardized tool to measure HRQoL. The 15D score and the dimensional level values range from 0 to 1, score 1 indicating full health and 0 indicating death. The questionnaire was completed by 252 women with endometriosis at 31 years and 302 women at age 46 years. The corresponding numbers in the reference group were 2057 and 2626, respectively. Several confounding factors were also considered. MAIN RESULTS AND THE ROLE OF CHANCE: In women with endometriosis, HRQoL was lower both at fertile and at late fertile age when compared with women without endometriosis, yet the total score did not reach clinical significance, set as ±0.015 change in HRQoL total score (age 31 years: 0.944 vs 0.951, P = 0.04; age 46 years: 0.916 vs 0.924, P = 0.03). At age 31 years, the 15D single index scores on 'sleeping', 'depression', and 'distress' were impaired in women with endometriosis, whereas 'sleeping' was impaired at age 46 years in affected women. The HRQoL decreased both in endometriosis and reference groups over time from age 31 to 46 years. In the non-adjusted analysis, women with endometriosis had their HRQoL score in the lowest quartile as often as the women without endometriosis at 31 or 46 years (OR [95% CI] 1.33 [1.00-1.78]); age 46 years (1.28 [0.98-1.66]). However, when the adjusted risk model took into account BMI, education, and smoking, there was a significant risk for lower HRQoL in endometriosis cases at both time points (age 31 years: OR [95% CI] 1.42 [1.06-1.91]; age 46 years: 1.42 [1.06-1.89]) and at age 31 years when parity and contraceptive use were considered in the model (OR [95% CI] 1.40 [1.03-1.91]). Depression, infertility, pain, and poor general health seemed to contribute to impaired HRQoL. Moreover, in the subgroup analysis, women with self-reported endometriosis had a higher risk for lower HRQoL scores at fertile and late fertile age than women with a hospital-based disease code when compared with reference population. LIMITATIONS, REASONS FOR CAUTION: Given the well-known lack of awareness and diagnostic delay in endometriosis, there may be undiagnosed cases of endometriosis among the reference group that may have led to underestimations of the differences between the study groups. Moreover, we were not able to identify the type of intervention during hospitalization in the present dataset. Also, the ethnicity of this study population is rather homogenous and thus may not be generalized in other ethnicities. WIDER IMPLICATIONS OF THE FINDINGS: This is the first population-based data to show women with endometriosis presenting low HRQoL at fertile and even at late fertile age, although with only mild decrease compared to non-endometriosis cases. HRQoL-items like 'sleeping', 'depression', and 'distress' were affected giving the idea that these items should be targeted in patient care, noting that depression, infertility, pain, and poor general health contributed to lower HRQoL. On the other hand, supporting fertility, hormonal treatments and access to tertiary care may offer solutions to improve HRQoL in women suffering from endometriosis. STUDY FUNDING/COMPETING INTEREST(S): The study has been funded with grants received from the Finnish Society of Obstetrics and Gynaecology (S.V.), University of Oulu (S.V.), Paulo Foundation (S.V.), Gedeon Richter (S.V.), Sigrid Jusélius Foundation (T.T.P.), and Oulu University Hospital (T.T.P., H.-R.R., L.M.-P.). The NFBC1966 31-year follow-up received financial support from the University of Oulu Grant no. 65354, Oulu University Hospital Grant no. 2/97 and 8/97, Ministry of Health and Social Affairs Grant no. 23/251/97, 160/97 and 190/97, the National Institute for Health and Welfare, Helsinki Grant no. 54121 and the Regional Institute of Occupational Health, Oulu, Finland Grant no. 50621 and 54231. The NFBC1966 46-year follow-up received financial support from University of Oulu Grant no. 24000692, Oulu University Hospital Grant no. 24301140 and European Regional Development Fund (ERDF) Grant no. 539/2010 A31592. Authors have no conflict of interest to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Vuontisjärvi S, Rossi HR, Nordström T, et al. Women with endometriosis have decreased health-related quality of life until late fertile age: a population-based cohort analysis at ages 31 and 46 years. Hum Reprod. 2025. PMID: 40795399. doi:10.1093/humrep/deaf154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。